Updated Guidelines for the Treatment of Pulmonary Sarcoidosis

Jara‐Palomares, Luis; Caballero-Eraso, Candela; Díaz-Baquero, Alicia; Rodríguez-Portal, José Antonio

doi:10.5772/22760

Cited by 2 publications

(2 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…methotrexate, azathioprine, cyclophosphamide, leflunomide), cytokine inhibitors (e.g. thalidomide, pentoxifylline), antimalarial agents such as chloroquine are only indicated when the sarcoidosis does not respond to conventional treatment with oral corticosteroids, in patients with intolerance to corticosteroids, or in order to reduce he dosage of corticosteroids 14 .…”

Section: Discussionmentioning

confidence: 99%

A case report on Sarcoidosis

et al. 2015

View full text Add to dashboard Cite

Sarcoidosis is a multisystem disease that may involve almost any organ system. Infiltration with non-caseating granulomas is the hallmark of the disease, and it may result in various clinical manifestations. Since the first description of the disease by British dermatologist Jonathan Hutchison in 1869, sarcoidosis has been seen in almost every part of the world and continues to engender considerable interest among clinicians because of its unknown aetiology, protean manifestations, and variable course and prognosis. Here we report a 65-year old woman who presented to us with a rather atypical presentation of sarcoidosis- subcutaneous nodules. Later, on subsequent diagnostic work-up, she was found to have bilateral hilar and mediastinal lymphadenopathy and pulmonary reticular lesions. It is a bit unusual to have only subcutaneous nodules as the presenting complaint of sarcoidosis without any prominent systemic and respiratory symptoms, which is what prompted this report. DOI: http://dx.doi.org/10.3329/jdmc.v22i2.21549 J Dhaka Medical College, Vol. 22, No.2, October, 2013, Page 225-228

show abstract

Section: Discussionmentioning

confidence: 99%

A case report on Sarcoidosis

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Corticosteroids are the main treatment for sarcoidosis; however this can have adverse effects due to immunosuppression in untreated TB. Guidelines1 suggest that patients with pulmonary sarcoidosis can be managed conservatively, unless there is hypercalcaemia, or neurological or ocular involvement when systemic steroids are indicated. The patient received treatment 12 days after first presenting.…”

Section: Questionsmentioning

confidence: 99%